GSK hires AZ’s Miels to lead pharma division
New CEO poaches Luke Miels from rival
X
GSK hires AZ’s Miels to lead pharma division
https://pharmaphorum.com/news/gsk-hires-azs-miels-lead-pharma-division/
Rheumatoid arthritis
FDA delays decision on Lilly RA hopeful
Review extended by three months.
Challenge to UK Humira patent begins
Samsung to take on patent thicket surrounding Humira.
AbbVie bullish on Humira and near-term pipeline
Sales of Humira could peak above $18 billion – CEO
Roche’s Mabthera faces cut-price competition in EU
Blockbuster likely to face cheap near-copy for first time.
EU regulators back Lilly’s blockbuster RA pill
Pill could generate $2 billion sales.
Ablynx in talks with partners for RA drug
Biotech suffered setback after AbbVie decided against partnership.
Sanofi/Regeneron RA drug rejected in US
FDA has concerns over Sanofi manufacturing plant.